Pharmacy Articles

Pharmacy

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Montero M et al. - Colistin is a safe option for the treatment of MDRP infections, with acceptable clinical outcomes. However, bacteriological eradication is difficult to achieve, especially in COPD patients.

Related Articles

Atomic Force Microscopy Investigation of the Morphology and Topography of Colistin-Heteroresistant Acinetobacter baumannii Strains as a Function of Growth Phase and in Response to Colistin Treatment
Antimicrobial Agents and Chemotherapy, 11/20/09    Relevance Score: 90%

Colistin in the 21st century
Current Opinion in Infectious Diseases, 11/02/09    Relevance Score: 88%

Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature
International Journal of Infectious Diseases, 11/16/09    Relevance Score: 85%

Penetration of Colistin into Cerebrospinal Fluid
Antimicrobial Agents and Chemotherapy, 11/05/09    Relevance Score: 85%

Colistin and polymyxin B: A re-emergence
Indian Journal of Critical Care Medicine, 10/09/09    Relevance Score: 82%

Today in Antimicrobials...keeping you current

Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities
Phytotherapy Research, 12/09/09

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
The Lancet - Early Online Publication, 12/08/09

Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/08/09